CA2425368A1 - Nouveaux sulphoxybenzamides - Google Patents

Nouveaux sulphoxybenzamides Download PDF

Info

Publication number
CA2425368A1
CA2425368A1 CA002425368A CA2425368A CA2425368A1 CA 2425368 A1 CA2425368 A1 CA 2425368A1 CA 002425368 A CA002425368 A CA 002425368A CA 2425368 A CA2425368 A CA 2425368A CA 2425368 A1 CA2425368 A1 CA 2425368A1
Authority
CA
Canada
Prior art keywords
sulphoxybenzamides
new
medicaments
preparing
processes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002425368A
Other languages
English (en)
Other versions
CA2425368C (fr
Inventor
Ralf Anderskewitz
Kurt Schromm
Franz Birke
Hans Michael Jennewein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2425368A1 publication Critical patent/CA2425368A1/fr
Application granted granted Critical
Publication of CA2425368C publication Critical patent/CA2425368C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C305/00—Esters of sulfuric acids
    • C07C305/22—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to carbon atoms of six-membered aromatic rings
    • C07C305/24—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to carbon atoms of six-membered aromatic rings of non-condensed six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cardiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

La présente invention concerne de nouveaux sulfooxybenzamides de la formule (I) dans laquelle Z<0> est un groupe choisi parmi les formules -X<1>-(CH2)r-X<2>- et -CR<4>R<5>- ; A<1> et A<2> sont indépendamment l'un de l'autre des groupes 1,4-phénylène ou 1,3-phénylène éventuellements substitués par un ou plusieurs atomes halogène, des groupes C1-C8-alkyl, des groupes C2-C8-alcényl, des groupes C1-C8-haloalkyl ou des groupes C1-C8-alkoxy, Z<1> et Z<2> sont indépendamment l'un de l'autre un groupe de formule -X<3>-(CH2)8-X<4>- ou une liaison simple ; et, m et n sont indépendamment l'un de l'autre 0 ou 1, les restes R<1>, R<2>, R<3>, R<4>, R<5>, X<1>, X<2>, X<3>, X<4>, r et s ayant la signification donnée dans le descriptif. L'invention concerne également des procédés de fabrication des composés selon l'invention, et leur utilisation en tant qu'agents pharmaceutiques, en particulier en tant qu'antagonistes de leucotriène B4(LTB4).
CA002425368A 2000-10-24 2001-10-19 Nouveaux sulphoxybenzamides Expired - Fee Related CA2425368C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10052333A DE10052333A1 (de) 2000-10-24 2000-10-24 Neue Sulfooxybenzamide
DE10052333.1 2000-10-24
PCT/EP2001/012127 WO2002034715A1 (fr) 2000-10-24 2001-10-19 Derives benzamidine comportant un groupe sulfate, servant d'antagonistes de ltb4

Publications (2)

Publication Number Publication Date
CA2425368A1 true CA2425368A1 (fr) 2003-04-08
CA2425368C CA2425368C (fr) 2008-12-09

Family

ID=7660637

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002425368A Expired - Fee Related CA2425368C (fr) 2000-10-24 2001-10-19 Nouveaux sulphoxybenzamides

Country Status (8)

Country Link
EP (1) EP1332128A1 (fr)
JP (1) JP3917516B2 (fr)
AU (1) AU2002210558A1 (fr)
CA (1) CA2425368C (fr)
DE (1) DE10052333A1 (fr)
MX (1) MXPA03003465A (fr)
PE (1) PE20020542A1 (fr)
WO (1) WO2002034715A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE481968T1 (de) * 2004-07-14 2010-10-15 Inflammation Res Ct Company Lt Verfahren zur hemmung von tumormetastasierung
ATE460173T1 (de) * 2005-07-08 2010-03-15 Leopold Franzens Uni Innsbruck Verwendung von extrakten und inhaltsstoffen aus leontopodium zur steigerung der cholinergen funktion
CN100402494C (zh) * 2005-08-25 2008-07-16 江苏吴中苏药医药开发有限责任公司 肌醇硫酸酯铝及其制备方法和口服组合物、应用
JP2014515734A (ja) 2011-03-16 2014-07-03 クリエイティブ セラポーティクス ゲーエムベーハー 置換ジフェニル誘導体
US20200199168A1 (en) 2017-05-12 2020-06-25 Riken Class a gpcr-binding compound modifier

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59309630D1 (de) * 1992-02-05 1999-07-08 Boehringer Ingelheim Pharma Neue amidinderivate, ihre herstellung und verwendung als arzneimittel mit ltb4-antagonistischer wirkung
DE19546452A1 (de) * 1995-12-13 1997-06-19 Boehringer Ingelheim Kg Neue Phenylamidinderivate, Verfahren zu ihrer Herstelung und ihre Verwendung als Arzneimittel
DE19636689A1 (de) * 1996-09-10 1998-03-12 Boehringer Ingelheim Kg Neue Benzamidinderivate

Also Published As

Publication number Publication date
EP1332128A1 (fr) 2003-08-06
DE10052333A1 (de) 2002-05-02
AU2002210558A1 (en) 2002-05-06
CA2425368C (fr) 2008-12-09
PE20020542A1 (es) 2002-07-16
MXPA03003465A (es) 2004-12-06
JP2004512322A (ja) 2004-04-22
WO2002034715A1 (fr) 2002-05-02
JP3917516B2 (ja) 2007-05-23

Similar Documents

Publication Publication Date Title
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
WO2001032646A3 (fr) Nouveaux composes
IL160440A (en) Dihydropteridinones, method for producing the same and the use thereof as medicaments
WO2002048147A3 (fr) Composes therapeutiques
CA2450093A1 (fr) Polymorphe stable de flibanserine, procede de preparation associe et utilisation dudit polymorphe dans la preparation de medicaments
WO2003037860A3 (fr) Analogues de purine presentant une activite inhibitrice de hsp90
WO2003095455A3 (fr) Composes therapeutiques
WO2003016282A3 (fr) Nouveaux 1h-dihydropyrazoles substitues et leurs procedes de preparation et d&#39;utilisation
WO2003006425A3 (fr) Nouveaux composes convenant comme anti-inflammatoires, immuno-modulateurs et anti-proliferants
MXPA03011972A (es) Arilaminas para tratamiento de condiciones asociadas con gsk-3.
WO2002008194A8 (fr) Derives acridine et utilisation en tant qu&#39;agents pharmaceutiques
CA2400268A1 (fr) Derives de pyrrolopyrimidinone, procedes d&#39;elaboration et d&#39;utilisation
CA2378148A1 (fr) Trifluorobutenes nematicides
MXPA02011370A (es) Iminoazinas substituidas.
WO2001082909A3 (fr) Derives de 2-acyl-indole et leur utilisation comme agents antitumoraux
CA2470809A1 (fr) Derives de 6-aminomorphinane et methode de production et utilisation connexes
WO2002010152A3 (fr) Nouveaux derives d&#39;indol et leur utilisation comme medicaments
CA2462998A1 (fr) Nouveaux composes oestrogeniques
CA2356985A1 (fr) Antagonistes du recepteur 5ht1 pour therapie antidepressive
GB0229081D0 (en) Multifunctional cationic photoinitiators, their preparation and use
CA2362217A1 (fr) Methode de preparation d&#39;intermediaires de pesticide a base de phenylpyrazole
WO2001049654A3 (fr) Derives d&#39;aminomethyle-phenyle-cyclohexane substitues
WO2002016322A3 (fr) Nouveau procede
WO2000059862A3 (fr) Procedes destines a la preparation de produits intermediaires pesticides
AU2002248531A1 (en) Pyrazolopyriadine derivatives

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed